Murine leukemias with retroviral insertions at Lmo2 are predictive of the leukemias induced in SCID-X1 patients following retroviral gene therapy.

Five X-linked severe combined immunodeficiency patients (SCID-X1) successfully treated with autologous bone marrow stem cells infected ex vivo with an IL2RG-containing retrovirus subsequently developed T-cell leukemia and four contained insertional mutations at LMO2. Genetic evidence also suggests a...

Full description

Saved in:
Bibliographic Details
Main Authors: Utpal P Davé, Keiko Akagi, Rati Tripathi, Susan M Cleveland, Mary A Thompson, Ming Yi, Robert Stephens, James R Downing, Nancy A Jenkins, Neal G Copeland
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2009-05-01
Series:PLoS Genetics
Online Access:https://journals.plos.org/plosgenetics/article/file?id=10.1371/journal.pgen.1000491&type=printable
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850108106169647104
author Utpal P Davé
Keiko Akagi
Rati Tripathi
Susan M Cleveland
Mary A Thompson
Ming Yi
Robert Stephens
James R Downing
Nancy A Jenkins
Neal G Copeland
author_facet Utpal P Davé
Keiko Akagi
Rati Tripathi
Susan M Cleveland
Mary A Thompson
Ming Yi
Robert Stephens
James R Downing
Nancy A Jenkins
Neal G Copeland
author_sort Utpal P Davé
collection DOAJ
description Five X-linked severe combined immunodeficiency patients (SCID-X1) successfully treated with autologous bone marrow stem cells infected ex vivo with an IL2RG-containing retrovirus subsequently developed T-cell leukemia and four contained insertional mutations at LMO2. Genetic evidence also suggests a role for IL2RG in tumor formation, although this remains controversial. Here, we show that the genes and signaling pathways deregulated in murine leukemias with retroviral insertions at Lmo2 are similar to those deregulated in human leukemias with high LMO2 expression and are highly predictive of the leukemias induced in SCID-X1 patients. We also provide additional evidence supporting the notion that IL2RG and LMO2 cooperate in leukemia induction but are not sufficient and require additional cooperating mutations. The highly concordant nature of the genetic events giving rise to mouse and human leukemias with mutations at Lmo2 are an encouraging sign to those wanting to use mice to model human cancer and may help in designing safer methods for retroviral gene therapy.
format Article
id doaj-art-a5b7392dd5524f7c8d5a9bf7304d5f68
institution OA Journals
issn 1553-7390
1553-7404
language English
publishDate 2009-05-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS Genetics
spelling doaj-art-a5b7392dd5524f7c8d5a9bf7304d5f682025-08-20T02:38:27ZengPublic Library of Science (PLoS)PLoS Genetics1553-73901553-74042009-05-0155e100049110.1371/journal.pgen.1000491Murine leukemias with retroviral insertions at Lmo2 are predictive of the leukemias induced in SCID-X1 patients following retroviral gene therapy.Utpal P DavéKeiko AkagiRati TripathiSusan M ClevelandMary A ThompsonMing YiRobert StephensJames R DowningNancy A JenkinsNeal G CopelandFive X-linked severe combined immunodeficiency patients (SCID-X1) successfully treated with autologous bone marrow stem cells infected ex vivo with an IL2RG-containing retrovirus subsequently developed T-cell leukemia and four contained insertional mutations at LMO2. Genetic evidence also suggests a role for IL2RG in tumor formation, although this remains controversial. Here, we show that the genes and signaling pathways deregulated in murine leukemias with retroviral insertions at Lmo2 are similar to those deregulated in human leukemias with high LMO2 expression and are highly predictive of the leukemias induced in SCID-X1 patients. We also provide additional evidence supporting the notion that IL2RG and LMO2 cooperate in leukemia induction but are not sufficient and require additional cooperating mutations. The highly concordant nature of the genetic events giving rise to mouse and human leukemias with mutations at Lmo2 are an encouraging sign to those wanting to use mice to model human cancer and may help in designing safer methods for retroviral gene therapy.https://journals.plos.org/plosgenetics/article/file?id=10.1371/journal.pgen.1000491&type=printable
spellingShingle Utpal P Davé
Keiko Akagi
Rati Tripathi
Susan M Cleveland
Mary A Thompson
Ming Yi
Robert Stephens
James R Downing
Nancy A Jenkins
Neal G Copeland
Murine leukemias with retroviral insertions at Lmo2 are predictive of the leukemias induced in SCID-X1 patients following retroviral gene therapy.
PLoS Genetics
title Murine leukemias with retroviral insertions at Lmo2 are predictive of the leukemias induced in SCID-X1 patients following retroviral gene therapy.
title_full Murine leukemias with retroviral insertions at Lmo2 are predictive of the leukemias induced in SCID-X1 patients following retroviral gene therapy.
title_fullStr Murine leukemias with retroviral insertions at Lmo2 are predictive of the leukemias induced in SCID-X1 patients following retroviral gene therapy.
title_full_unstemmed Murine leukemias with retroviral insertions at Lmo2 are predictive of the leukemias induced in SCID-X1 patients following retroviral gene therapy.
title_short Murine leukemias with retroviral insertions at Lmo2 are predictive of the leukemias induced in SCID-X1 patients following retroviral gene therapy.
title_sort murine leukemias with retroviral insertions at lmo2 are predictive of the leukemias induced in scid x1 patients following retroviral gene therapy
url https://journals.plos.org/plosgenetics/article/file?id=10.1371/journal.pgen.1000491&type=printable
work_keys_str_mv AT utpalpdave murineleukemiaswithretroviralinsertionsatlmo2arepredictiveoftheleukemiasinducedinscidx1patientsfollowingretroviralgenetherapy
AT keikoakagi murineleukemiaswithretroviralinsertionsatlmo2arepredictiveoftheleukemiasinducedinscidx1patientsfollowingretroviralgenetherapy
AT ratitripathi murineleukemiaswithretroviralinsertionsatlmo2arepredictiveoftheleukemiasinducedinscidx1patientsfollowingretroviralgenetherapy
AT susanmcleveland murineleukemiaswithretroviralinsertionsatlmo2arepredictiveoftheleukemiasinducedinscidx1patientsfollowingretroviralgenetherapy
AT maryathompson murineleukemiaswithretroviralinsertionsatlmo2arepredictiveoftheleukemiasinducedinscidx1patientsfollowingretroviralgenetherapy
AT mingyi murineleukemiaswithretroviralinsertionsatlmo2arepredictiveoftheleukemiasinducedinscidx1patientsfollowingretroviralgenetherapy
AT robertstephens murineleukemiaswithretroviralinsertionsatlmo2arepredictiveoftheleukemiasinducedinscidx1patientsfollowingretroviralgenetherapy
AT jamesrdowning murineleukemiaswithretroviralinsertionsatlmo2arepredictiveoftheleukemiasinducedinscidx1patientsfollowingretroviralgenetherapy
AT nancyajenkins murineleukemiaswithretroviralinsertionsatlmo2arepredictiveoftheleukemiasinducedinscidx1patientsfollowingretroviralgenetherapy
AT nealgcopeland murineleukemiaswithretroviralinsertionsatlmo2arepredictiveoftheleukemiasinducedinscidx1patientsfollowingretroviralgenetherapy